|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,097.00 ILa | +3.30% |
|
+0.73% | +0.27% |
| Market Cap | 125M 0 41.11M 36.11M 33.58M 30.82M 57.9M 3.96B 58.79M 399M 156M 1.95B 154M 151M 6.73B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 253M 0 83.14M 73.03M 67.91M 62.32M 117M 8.01B 119M 806M 315M 3.94B 312M 305M 13.61B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +3.30% | ||
| 1 week | +0.73% | ||
| Current month | +2.91% | ||
| 1 month | +3.20% | ||
| 3 months | -6.24% | ||
| 6 months | -12.73% | ||
| Current year | +0.27% |
| 1 week | 1,040 |  | 1,105 |
| 1 month | 1,006 | | 1,133 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,788 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1993-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 2018-10-31 |
| President | 80 | 2010-06-27 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 2010-06-24 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 79 | 2015-04-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.30% | +0.73% | -8.51% | -39.16% | 39.4M | |
| +1.99% | -0.05% | +17.77% | +102.99% | 96.53B | |
| +0.91% | -0.30% | +44.54% | +144.69% | 52.93B | |
| -1.05% | -3.40% | -0.70% | +246.34% | 23.01B | |
| -1.27% | -3.87% | -14.24% | -19.71% | 8.23B | |
| -5.96% | -10.58% | -33.52% | -34.90% | 7.87B | |
| -0.53% | -5.45% | -11.83% | -29.83% | 6.74B | |
| -0.80% | +0.67% | +24.62% | +26.56% | 6.22B | |
| -0.52% | -1.98% | -1.42% | +19.83% | 5.31B | |
| -0.99% | -4.21% | -7.39% | -8.14% | 3.72B | |
| Average | -0.40% | -2.92% | +0.93% | +40.87% | 21.06B | |
| Weighted average by Cap. | +0.90% | -2.33% | +17.63% | +108.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 106M 92.77M 86.28M 79.17M 149M 10.17B 151M 1.02B 400M 5B 397M 388M 17.29B | 301M 0 98.82M 86.8M 80.72M 74.07M 139M 9.52B 141M 959M 374M 4.68B 371M 363M 16.18B |
| Net income | 6.21M 0 2.04M 1.79M 1.66M 1.53M 2.87M 196M 2.91M 19.76M 7.72M 96.47M 7.65M 7.48M 334M | -18.07M -0 -5.93M -5.21M -4.85M -4.45M -8.36M -571M -8.49M -57.56M -22.49M -281M -22.28M -21.8M -971M |
| Net Debt | 127M 0 41.73M 36.65M 34.08M 31.28M 58.76M 4.02B 59.67M 405M 158M 1.98B 157M 153M 6.83B | 128M 0 42.03M 36.92M 34.33M 31.5M 59.19M 4.05B 60.1M 408M 159M 1.99B 158M 154M 6.88B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | ILA 1,097.00 | +3.30% | 985 |
| 26-07-22 | ILA 1,062.00 | +0.66% | 268 |
| 26-07-21 | ILA 1,055.00 | -3.12% | 12,599 |
| 26-07-20 | ILA 1,089.00 | 0.00% | 2 |
| 26-07-17 | ILA 1,089.00 | 0.00% | 11 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
